References
- Bazerbachi F, Kermanshahi TR, Monteiro C. Early precursor of mixed endocrine-exocrine tumors of the gastrointestinal tract: Histologic and molecular correlations. Ochsner J 15, 97–101, 2015.
- Brathwaite S, Rock J, Yearsley MM, Bekaii-Saab T, Wei L, Frankel WL, Hays J, Wu C, Abdel-Misih S. Mixed adenoneuroendocrine carcinoma: An aggressive clinical entity. Ann Surg Oncol 23, 2281–2286, 2016.10.1245/s10434-016-5179-2
- Casas F, Ferrer F, Farrus B, Casals J, Biete A. Primary small cell carcinoma of the esophagus: a review of the literature with emphasis on therapy and prognosis. Cancer 80, 1366–7213, 1997.10.1002/(SICI)1097-0142(19971015)80:8<1366::AID-CNCR2>3.0.CO;2-D
- de Mestier L, Cros J, Neuzillet C, Hentic O, Egal A, Muller N, Bouche O, Cadiot G, Ruszniewski P, Couvelard A, Hammel P. Digestive system mixed neuroendocrine-non-neuroendocrine neoplasms. Neuroendocrinology 105, 412–425, 2017.10.1159/000475527
- Ho KJ, Herrera GA, Jones JM, Alexander CB. Small cell carcinoma of the esophagus: evidence for a unified histogenesis. Hum Pathol 15, 460–468, 1984.10.1016/S0046-8177(84)80081-7
- Kaluzny M, Bolanowski M, Sukiennik-Kujawa M, Ponikowski P, Handkiewicz-Junak D, Jarzab B, Jawiarczyk A, Syrycka J. Long-term survival and nearly asymptomatic course of carcinoid tumour with multiple metastases (treated by surgery, chemotherapy, (90)Y-DOTATATE, and LAR octreotide analogue): a case report. Endokrynol Pol 60, 401–406, 2009.
- Kanthan R, Tharmaradinam S, Asif T, Ahmed S, Kanthan SC. Mixed epithelial endocrine neoplasms of the colon and rectum - An evolution over time: A systematic review. World J Gastroenterol 26, 5181–5206, 2020.10.3748/wjg.v26.i34.5181
- Karkouche R, Bachet JB, Sandrini J, Mitry E, Penna C, Cote JF, Blons H, Penault-Llorca F, Rougier P, Saint Andre JP, Emile JF. Colorectal neuroendocrine carcinomas and adenocarcinomas share oncogenic pathways. A clinico-pathologic study of 12 cases. Eur J Gastroenterol Hepatol 24, 1430–1437, 2012.10.1097/MEG.0b013e3283583c87
- Kitajima T, Kaida S, Lee S, Haruta S, Shinohara H, Ueno M, Suyama K, Oota Y, Fujii T, Udagawa H. Mixed adeno(neuro)endocrine carcinoma arising from the ectopic gastric mucosa of the upper thoracic esophagus. World J Surg Onc 11, 218, 2013.10.1186/1477-7819-11-218
- Komatsubara T, Koinuma K, Miyakura Y, Horie H, Morimoto M, Ito H, Lefor AK, Sata N, Fukushima N. Endocrine cell carcinomas of the colon and rectum: a clinicopathological evaluation. Clin J Gastroenterol 9, 1–6, 2016.10.1007/s12328-015-0623-6
- Konishi T, Watanabe T, Kishimoto J, Kotake K, Muto T, Nagawa H; Japanese Society for Cancer of the Colon and Rectum. Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years. Gut 56, 863–868, 2007.10.1136/gut.2006.109157
- La Rosa S, Marando A, Furlan D, Sahnane N, Capella C. Colorectal poorly differentiated neuroendocrine carcinomas and mixed adenoneuroendocrine carcinomas: insights into the diagnostic immunophenotype, assessment of methylation profile, and search for prognostic markers. Am J Surg Pathol 36, 601–611, 2012.10.1097/PAS.0b013e318242e21c
- La Rosa S, Sessa F, Uccella S. Mixed neuroendocrine-nonneuroendocrine neoplasms (MiNENs): Unifying the concept of a heterogeneous group of neoplasms. Endocr Pathol 27, 284–311, 2016.10.1007/s12022-016-9432-927169712
- Lewin K. Carcinoid tumors and the mixed (composite) glandular-endocrine cell carcinomas. Am J Surg Pathol 11 Suppl 1, 71–86, 1987.10.1097/00000478-198700111-000073544888
- Li Y, Yau A, Schaeffer D, Magliocco A, Gui X, Urbanski S, Waghray R, Owen D, Gao ZH. Colorectal glandular-neuroendocrine mixed tumor: pathologic spectrum and clinical implications. Am J Surg Pathol 35, 413–425, 2011.10.1097/PAS.0b013e318209365721317713
- Maggard MA, O’Connell JB, Ko CY. Updated population-based review of carcinoid tumors. Ann Surg 240, 117–122, 2004.10.1097/01.sla.0000129342.67174.67135638315213627
- Modlin IM, Gustafsson BI, Moss SF, Pavel M, Tsolakis AV, Kidd M. Chromogranin A-biological function and clinical utility in neuro endocrine tumor disease. Ann Surg Oncol 17, 2427, 2010.10.1245/s10434-010-1006-320217257
- Montminy EM, Zhou M, Maniscalco L, Abualkhair W, Kim MK, Siegel RL, Wu XC, Itzkowitz SH, Karlitz JJ. Contributions of adenocarcinoma and carcinoid tumors to early-onset colorectal cancer incidence rates in the United States. Ann Intern Med 174, 157–166, 2021.10.7326/M20-006833315473
- Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, Washington KM, Carneiro F, Cree IA and Board, WHO Classification of Tumours Editorial. The 2019 WHO classification of tumours of the digestive system. Histopathology 76, 182–188, 2020.10.1111/his.13975700389531433515
- Nikou GC, Lygidakis NJ, Toubanakis C, Pavlatos S, Tseleni-Balafouta S, Giannatou E, Mallas E, Safioleas M. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues. Hepatogastroenterology 52, 731–741, 2005.
- Paspala A, Machairas N, Prodromidou A, Spartalis E, Ioannidis A, Kostakis ID, Papaconstantinou D, Nikiteas N. Management of MANEC of the colon and rectum: A comprehensive review of the literature. Mol Clin Oncol 9, 219–222, 2018.10.3892/mco.2018.1649608340830101026
- Smith JD, Reidy DL, Goodman KA, Shia J, Nash GM. A retrospective review of 126 high-grade neuroendocrine carcinomas of the colon and rectum. Ann Surg Oncol 21, 2956–2962, 2014.10.1245/s10434-014-3725-3452162224763982
- Taghavi S, Jayarajan SN, Powers BD, Davey A, Willis AI. Examining rectal carcinoids in the era of screening colonos-copy: a surveillance, epidemiology, and end results analysis. Dis Colon Rectum 56, 952–959, 2013.10.1097/DCR.0b013e318291f51223838863
- Tanaka T, Kaneko M, Nozawa H, Emoto S, Murono K, Otani K, Sasaki K, Nishikawa T, Kiyomatsu T, Hata K, Morikawa T, Kawai K, Watanabe T. Diagnosis, assessment, and therapeutic strategy for colorectal mixed adenoneuroendocrine carcinoma. Neuroendocrinology 105, 426–434, 2017.10.1159/000478743
- Volante M, Rindi G, Papotti M. The grey zone between pure (neuro)endocrine and non-(neuro)endocrine tumours: a comment on concepts and classification of mixed exocrine–endocrine neoplasms. Virchows Arch 449, 499–506, 2006.10.1007/s00428-006-0306-2
- Waisberg DR, Fava AS, Martins LC, Matos LL, Franco MI, Waisberg J. Colonic carcinoid tumors: a clinicopathologic study of 23 patients from a single institution. Arq Gastroenterol 46, 288–293, 2009.10.1590/S0004-28032009000400008
- Watanabe J, Suwa Y, Ota M, Ishibe A, Masui H, Nagahori K, Tsuura Y, Endo I. Clinicopathological and prognostic evaluations of mixed adenoneuroendocrine carcinoma of the colon and rectum: A case-matched study. Dis Colon Rectum 59, 1160–1167, 2016.10.1097/DCR.0000000000000702
- Williams ED, Sandler M. The classification of carcinoid tumours. Lancet 1(7275), 238–239, 1963.10.1016/S0140-6736(63)90951-6